Ntv.Bk
NTV.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare services and pharmaceutical products.
Business. NTV.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare services and pharmaceutical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
NTV.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare services and pharmaceutical products.
NTV.BK maintains a strong liquidity position, as evidenced by a current ratio of 5.78, indicating that the company has significantly more current assets than current liabilities. The company also has no long-term debt, which further supports its liquidity profile.
In terms of profitability, NTV.BK demonstrates a return on equity (ROE) of 9.82% and a return on assets (ROA) of 8.72%. These figures are strong indicators of the company's ability to generate profits relative to its equity and total assets, respectively.
The company's revenue is primarily derived from its operations in the healthcare sector, with a focus on pharmaceuticals and healthcare facilities and services. There is no specific information provided on geographic or segment revenue concentration, but the company's primary business is centered around these core activities.
NTV.BK has shown consistent growth in its financial performance, with a net income of 276,755,060 THB and an operating income of 321,628,790 THB. The company's capital expenditure of -233,650,080 THB indicates a reduction in capital spending, which may be a strategic move to preserve cash or reinvest in more profitable areas.
The risk assessment for NTV.BK indicates a low level of liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, suggesting a stable financial position. Additionally, the absence of long-term debt and the strong current ratio contribute to a favorable risk profile.
Recent events and filings for NTV.BK do not indicate any significant changes or risks that would impact the company's financial stability. The company's financial statements and disclosures are consistent with a well-managed and stable business operation.
- NTV.BK has a strong liquidity position with a current ratio of 5.78 and no long-term debt.
- The company's profitability is reflected in a ROE of 9.82% and a ROA of 8.72%.
- NTV.BK's operations are primarily focused on pharmaceuticals and healthcare facilities and services.
- The company has shown consistent financial performance with a net income of 276,755,060 THB.
- NTV.BK has a low risk of liquidity and dilution, with no immediate filing-based flags detected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- NTV.BK Market data — financials · 2026-05-28